Crimson Contagion

From WikiMD's Food, Medicine & Wellness Encyclopedia

Crimson Contagion was a simulation administered by the United States Department of Health and Human Services (HHS) from January to August 2019 that tested the capacity of the U.S. federal government and twelve U.S. states to respond to a severe influenza pandemic originating from China.

Background[edit | edit source]

The Crimson Contagion scenario was a hypothetical outbreak of a novel strain of influenza, H7N9, which is a type of Avian Influenza. The exercise involved a scenario in which tourists returning from China spread the disease in their home countries, with the first detection in the United States occurring in Chicago.

Simulation[edit | edit source]

The simulation was designed to test the nation's capacity to respond to a large-scale outbreak. The exercise revealed that the U.S. was unprepared for a pandemic, with issues including a lack of funding, confusion about who was in charge, and a lack of coordination between federal, state, and local governments.

Findings[edit | edit source]

The exercise found that the U.S. was "underfunded, underprepared, and uncoordinated" in the face of a pandemic. It also found that the U.S. lacked the manufacturing capacity to produce necessary medical equipment, such as ventilators and personal protective equipment (PPE), in a timely manner.

Aftermath[edit | edit source]

The findings of the Crimson Contagion exercise were presented in a draft report in October 2019, just months before the start of the COVID-19 pandemic. The exercise has been cited as evidence of the U.S. government's awareness of the threat posed by pandemics and its lack of preparedness to deal with them.

See also[edit | edit source]

References[edit | edit source]


External links[edit | edit source]

Template:Influenza-stub

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD